Supplementary data: Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests

Supplemental Table S1. SARS-CoV-2 Variants Included in the Analysis Supplemental Table S2. Anti-nucleocapsid Antibodies Used in Each Assay Supplemental Figure S1. Representative immunoblots of all recombinant SARS-CoV-2 nucleocapsid antigens (rAg; see Table 1) with anti-nucleocapsid antibodies used in the Panbio assay (Ab1, Ab2) and BinaxNOW assay (Ab3, Ab4). Supplemental Figure S2. Normalized Sensorgrams of Ab1 Binding Captured SARS-CoV-2 Nucleocapsids. Supplemental Figure S3. Normalized Sensorgrams of Ab2 Binding Captured SARS-CoV-2 Nucleocapsids